Abstract
What developments have been made in collaborative research and clinical trials?
Highlights
In 2012, the National Cancer Research Institute (NCRI) produced a report highlighting approaches needed to grow and sustain critical mass in surgical oncology research (Table 1).[1]
The number of patients recruited in 2017–2018 maintained the impressive data for the previous year at just under 12,000 (Figure 1). 2017–18 saw the highest ever number of surgical patients recruited to randomised controlled trials, forming 77% of the surgical oncology portfolio, with 8,863 patients recruited
Despite historical perceptions that surgery has lagged behind other medical disciplines in collaborative research and clinical trials, substantial progress has been made
Summary
R Shaw National Specialty Lead for Surgical Oncology S Anwar Specialty Cluster Manager (Cancer, Surgery, and Oral and Dental Health) NIHR Clinical Research Network. GROWING RECRUITMENT In order to better understand the trends, the National Institute for Health Research (NIHR) Clinical Research Network has flagged which cancer trials are recruited to by surgeons. These trials include those where surgery is the primary trial intervention and multimodality trials where the surgeon leads recruitment. Of the 126 surgical oncology trials open in 2017–2018, 73% recruited well to time and target, which is the same proportion as for the wider portfolio of cancer studies These data disabuse the notion that surgeons do not recruit to trials or that surgical trials usually fail. Breakout session chaired by Mr Hassan Malik at the Tomorrow’s Leaders workshop in 2017
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Bulletin of the Royal College of Surgeons of England
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
